Vilazodone Hydrochloride
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
69097-979 -
Package NDC
69097-979-02 -
Application number
ANDA208200 -
SPL ID
e16f2d8b-a5ec-498f-97c4-d1c9d897140f -
SPL set ID
658c4bc1-4128-4e0e-8852-b5f68880e8d7 -
UNII
U8HTX2GK8J -
RxCUI
1086772 -
RxCUI
1086778 -
RxCUI
1086784
What the source publishes
- Labeler
- Cipla USA Inc.
- Active ingredients
- Vilazodone Hydrochloride
- Form
- TABLET, FILM COATED
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Vilazodone Hydrochloride",
"splId": "e16f2d8b-a5ec-498f-97c4-d1c9d897140f",
"labels": [
{
"setId": "658c4bc1-4128-4e0e-8852-b5f68880e8d7",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=658c4bc1-4128-4e0e-8852-b5f68880e8d7",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=658c4bc1-4128-4e0e-8852-b5f68880e8d7"
}
],
"routes": [
"ORAL"
],
"labeler": "Cipla USA Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "30 TABLET, FILM COATED in 1 BOTTLE (69097-979-02)",
"package_ndc": "69097-979-02",
"identifierStatus": "well-formed",
"marketing_start_date": "20230123"
}
],
"productId": "69097-979_e16f2d8b-a5ec-498f-97c4-d1c9d897140f",
"useDomain": "unknown",
"dosageForm": "TABLET, FILM COATED",
"productNdc": "69097-979",
"deaSchedule": null,
"genericName": "Vilazodone Hydrochloride",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "VILAZODONE HYDROCHLORIDE",
"strength": "10 mg/1"
}
],
"applicationNumber": "ANDA208200",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20230123",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"upc": [
"0369097981020",
"0369097979027",
"0369097982027"
],
"unii": [
"U8HTX2GK8J"
],
"rxcui": [
"1086772",
"1086778",
"1086784"
],
"spl_set_id": [
"658c4bc1-4128-4e0e-8852-b5f68880e8d7"
],
"manufacturer_name": [
"Cipla USA Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:69097-979_e16f2d8b-a5ec-498f-97c4-d1c9d897140f"